3-Amino-5-chloro-N-cyclopropyl-6-methoxy-4-methylthieno[2,3-b]pyridine-2-carboxamide
| Title | Journal |
|---|---|
| LY2033298, a positive allosteric modulator at muscarinic M₄ receptors, enhances inhibition by oxotremorine of light-induced phase shifts in hamster circadian activity rhythms. | Psychopharmacology 20121101 |
| Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects. | Molecular pharmacology 20120101 |
| Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor. | British journal of pharmacology 20110401 |
| Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100301 |
| New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug). | Molecular pharmacology 20081001 |
| Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. | Proceedings of the National Academy of Sciences of the United States of America 20080805 |
| An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission. | Nature chemical biology 20080101 |